1. Home
  2. ELTX vs MYPS Comparison

ELTX vs MYPS Comparison

Compare ELTX & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$8.06

Market Cap

141.3M

Sector

Health Care

ML Signal

HOLD

Logo PLAYSTUDIOS Inc.

MYPS

PLAYSTUDIOS Inc.

HOLD

Current Price

$0.64

Market Cap

114.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
MYPS
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
141.3M
114.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ELTX
MYPS
Price
$8.06
$0.64
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$13.00
$2.00
AVG Volume (30 Days)
91.3K
192.6K
Earning Date
11-13-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,477,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.60
$0.57
52 Week High
$12.62
$1.99

Technical Indicators

Market Signals
Indicator
ELTX
MYPS
Relative Strength Index (RSI) 45.74 43.27
Support Level $7.77 $0.64
Resistance Level $8.31 $0.67
Average True Range (ATR) 0.35 0.03
MACD 0.03 0.00
Stochastic Oscillator 27.16 23.74

Price Performance

Historical Comparison
ELTX
MYPS

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About MYPS PLAYSTUDIOS Inc.

PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.

Share on Social Networks: